Arrival Stock News

Add these penny stocks to your March 2022 watchlist The post Hot Penny Stocks to Buy Right Now? 3 to Watch in March 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock

LUXEMBOURG, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Arrival (NASDAQ: ARVL), pioneer of a unique new method of design and production of affordable electric vehicles (EVs) by local Microfactories, today ann

Add these penny stocks to your March 2022 watchlist The post Hot Penny Stocks to Buy Right Now? 3 to Watch in March 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock

SAN DIEGO, Feb. 20, 2022 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Arrival SA (NASDAQ: ARVL) common shares between November 18, 2020 and November 19, 2021, inclusive (the Class Period) have until this upcoming Tuesday, February 22, 2022 to seek appointment in Schmutter v. Arrival SA , No. 21-cv-11016 (S.D.N.Y.). Commenced on December 22, 2021, the Arrival class action lawsuit charges Arrival and certain of its top executives with violations of the Securities Exchange Act of 1934. A similar lawsuit, Sanchez v. Arrival SA , No. 22-cv-00172 (E.D.N.Y.), is pending in the Eastern District of New York.

SAN DIEGO, Feb. 19, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Arrival SA (NASDAQ: ARVL) common shares between November 18, 2020 and November 19, 2021, inclusive (the "Class Period") have until this upcoming Tuesday, February 22,

NEW YORK, Feb. 19, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Arrival SA (NASDAQ: ARVL) between November 18, 2020 and November 19, 2021, inclusive (the "Class Period"), of the important February 22, 2022 lead

SAN DIEGO--(BUSINESS WIRE)-- #ARVLstock--The suit alleges defendants issued false statements concerning Arrival business and prospects, resulting in its stock trading at inflated prices.

NEW YORK, Feb. 18, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Arrival SA (NASDAQ: ARVL ) between November 18, 2020 and November 19, 2021, inclusive (the "Class Period"), of the important February 22 , 2022 lead plaintiff deadline . SO WHAT: If you purchased Arrival securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Arrival class action, go to https://rosenlegal.com/submit-form/?case_id=3065 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 22 , 2022 . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Stocks under $10 that can double in the next 12-months. Non-speculative stocks with positive tailwinds for growth.

The economical and technological stars have aligned, and EVs are poised to go mainstream this year. Buy into EV stocks now before they go sky-high.

NEW YORK, Feb. 15, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Arrival SA. (NASDAQ: ARVL) alleging that the Company violated federal securities laws. This lawsuit is on behalf of a class consisting of persons…

EV penny stocks to watch after DeLorean Electric Vehicle speculation. The post 4 Penny Stocks To Watch After DeLorean's Electric Vehicle Comeback appeared first on Penny Stocks to Buy, Picks, News and

NEW YORK, Feb. 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Reata Pharmaceuticals, Inc. (NASDAQ: RETA ), Desktop Metal, Inc. (NYSE: DM ), DocuSign, Inc. (NASDAQ: DOCU ), and Arrival SA (NASDAQ: ARVL ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Reata Pharmaceuticals, Inc. (NASDAQ: RETA ) Class Period: November 14, 2016 December 8, 2021 Lead Plaintiff Deadline: February 18, 2022 The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company''s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the FDA had raised concerns regarding the validity of the clinical study designed to measure the efficacy and safety of bardoxolone for the treatment of chronic kidney disease caused by Alport syndrome; (2) that, as a result, there was a material risk that Reata''s NDA would not be approved; and (3) that, as a result of the foregoing, Defendants'' positive statements about the Company''s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Although the market is full of potential pitfalls, risk-tolerant contrarians could consider these discounted stocks to buy. The post 7 Badly Bruised Stocks to Buy for the Tough-as-Nails Contrarian app

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Arrival SA (NASDAQ: ARVL) between November 18, 2020 and November 19, 2021, inclusive (the “Class Period”), of the important February 22, 2022 lead plaintiff deadline .